Cargando…
Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression
Chronic kidney disease (CKD) patients accumulate uremic toxins in the body, potentially require dialysis, and can eventually develop cardiovascular disease. CKD incidence has increased worldwide, and preventing CKD progression is one of the most important goals in clinical treatment. In this study,...
Autores principales: | Takada, T., Yamamoto, T., Matsuo, H., Tan, J. K., Ooyama, K., Sakiyama, M., Miyata, H., Yamanashi, Y., Toyoda, Y., Higashino, T., Nakayama, A., Nakashima, A., Shinomiya, N., Ichida, K., Ooyama, H., Fujimori, S., Suzuki, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057959/ https://www.ncbi.nlm.nih.gov/pubmed/30042379 http://dx.doi.org/10.1038/s41598-018-29208-w |
Ejemplares similares
-
Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2
por: Matsuo, Hirotaka, et al.
Publicado: (2016) -
Multiple common and rare variants of ABCG2 cause gout
por: Higashino, Toshihide, et al.
Publicado: (2017) -
Uremic Retention Solute Indoxyl Sulfate Level Is Associated with Prolonged QTc Interval in Early CKD Patients
por: Tang, Wei-Hua, et al.
Publicado: (2015) -
Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice
por: Caggiano, Gianvito, et al.
Publicado: (2023) -
Binding Affinity and Capacity for the Uremic Toxin Indoxyl Sulfate
por: Devine, Eric, et al.
Publicado: (2014)